Figure Gallery

Expression Pattern Search Results for myb

(467 figures with expression from 235 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Gore et al., 2016	Fig. 1 S1	EKW	standard conditions	Prim-25	eye head
	Fig. 3	y278Tg; zf169Tg + MO2-dnmt3bb.1	standard conditions	Prim-25	hematopoietic multipotent progenitor cell
Grainger et al., 2016	Fig. 3	AB WT wnt9a^sd49/sd49 AB + MO2-wnt9a wnt9a^sd49/+	standard conditions	Prim-25 to Day 4	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 5	AB AB + MO2-wnt9a	standard conditions	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 2	sd32Tg; sd46Tg sd46Tg; ubs4Tg	control heat shock	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 1	w26Tg	control heat shock	Prim-15 to Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
Han et al., 2016	Fig. 5	WT WT + MO1-hal WT + MO1-mettl22 WT + MO2-ap2a1 WT + MO2-prdm16 WT + MO3-lrsam1	standard conditions control	Prim-15	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. S3F	WT WT + MO1-hal WT + MO1-mettl22 WT + MO2-ap2a1 WT + MO2-prdm16 WT + MO3-lrsam1	standard conditions control	Long-pec	ventral wall of dorsal aorta
Konantz et al., 2016	Fig. 4	TU + MO5-mecom + MO6-mecom nc2aTg + MO5-mecom + MO6-mecom kca3Tg; kca4Tg + MO5-mecom + MO6-mecom kca3Tg; mu101Tg + MO5-mecom + MO6-mecom	control heat shock	Prim-25	hematopoietic multipotent progenitor cell
	Fig. 7	TU TU + MO5-mecom + MO6-mecom kca3Tg; kca4Tg nkuasrfp1aTg; ubs3Tg + MO5-mecom + MO6-mecom	standard conditions control chemical treatment: wortmannin	Prim-15 to Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 1	TU TU + MO5-mecom + MO6-mecom	standard conditions control	Prim-25	hematopoietic multipotent progenitor cell
	Fig. 6	TU	control chemical treatment: semaxanib	Prim-15	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. S1	TU	standard conditions	Prim-15 to Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 3	ubs16Tg; zf169Tg + MO5-mecom + MO6-mecom	standard conditions	Prim-15	angioblastic mesenchymal cell
Kwan et al., 2016	Fig. 6	WT nr3c1^s357/s357	standard conditions	Protruding-mouth	hematopoietic multipotent progenitor cell
	Fig. 2	WT WT + MO1-tph1a WT + MO1-tph1b WT + MO2-tph2 WT + MO1-tph1a + MO1-tph1b WT + MO1-tph1a + MO1-tph1b + MO2-tph2	standard conditions control chemical treatment by environment: 4-chloro-L-phenylalanine	Prim-15 to Long-pec	hematopoietic multipotent progenitor cell ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 1	WT	control chemical treatment by environment: serotonin chemical treatment by environment: fluoxetine	Prim-5 to Protruding-mouth	hematopoietic multipotent progenitor cell ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 3	WT y226Tg	control chemical ablation: serotonergic neuron, chemical treatment by environment: metronidazole chemical treatment by environment: metronidazole	Protruding-mouth	hematopoietic multipotent progenitor cell whole organism
	Fig. 4	WT	control chemical treatment by environment: serotonin, chemical treatment by environment: oxidopamine, chemical treatment by environment: nepicastat chemical treatment by environment: nepicastat, chemical treatment by environment: oxidopamine chemical treatment by environment: serotonin	Protruding-mouth	hematopoietic multipotent progenitor cell whole organism
	Fig. 5	WT	control chemical treatment by environment: dexamethasone chemical treatment by environment: cortisol	Protruding-mouth	hematopoietic multipotent progenitor cell whole organism
Mahony et al., 2016	Fig. 2	AB	standard conditions	Day 4	hematopoietic multipotent progenitor cell hematopoietic stem cell thymus hematopoietic multipotent progenitor cell thymus hematopoietic stem cell
	Fig. 4	bw9Tg bw9Tg; ug102Tg	standard conditions	Day 4	hematopoietic stem cell
	Fig. 3	WT tfec^ug103/ug103	standard conditions	Day 4	hematopoietic stem cell
	Fig. 6	WT tfec^ug103/ug103	standard conditions	Day 4	hematopoietic stem cell
Monteiro et al., 2016	Fig. 6	WT WT + MO1-tgfbr2b WT + MO2-jag1a	standard conditions	Prim-5 to Prim-15	ventral wall of dorsal aorta